No. |
Variant name |
Chromosome position |
Chromatin state |
Related regulatory elements |
Target genes |
Extended variants |
Associated traits |
1 |
rs1016338 |
chr2:205539092-205539093 |
Enhancers Weak transcription Genic enhancers
|
n/a
|
n/a
|
LD-proxies of rSNPOverlapped rCNV
|
mRNA abundance
|
2 |
rs540411644 |
chr2:205539112-205539113 |
Enhancers Weak transcription Genic enhancers
|
n/a
|
n/a
|
Overlapped CNVs
|
n/a
|
3 |
rs565212048 |
chr2:205539151-205539152 |
Enhancers Weak transcription Genic enhancers
|
n/a
|
n/a
|
Overlapped CNVs
|
n/a
|
4 |
rs185339992 |
chr2:205539163-205539164 |
Enhancers Weak transcription Genic enhancers
|
n/a
|
n/a
|
Overlapped CNVs
|
n/a
|
5 |
rs544487473 |
chr2:205539197-205539198 |
Enhancers Weak transcription Genic enhancers
|
n/a
|
n/a
|
Overlapped CNVs
|
n/a
|
6 |
rs1030087 |
chr2:205539214-205539215 |
Enhancers Weak transcription Genic enhancers
|
n/a
|
n/a
|
LD-proxies of rSNPOverlapped rCNV
|
n/a
|
7 |
rs144356578 |
chr2:205539233-205539234 |
Enhancers Weak transcription Genic enhancers
|
n/a
|
n/a
|
Overlapped CNVs
|
n/a
|
8 |
rs531558628 |
chr2:205539249-205539250 |
Enhancers Weak transcription Genic enhancers
|
n/a
|
n/a
|
Overlapped CNVs
|
n/a
|
9 |
rs377056330 |
chr2:205539251-205539252 |
Enhancers Weak transcription Genic enhancers
|
n/a
|
n/a
|
Overlapped CNVs
|
n/a
|
10 |
rs189651296 |
chr2:205539288-205539289 |
Enhancers Weak transcription Genic enhancers
|
n/a
|
n/a
|
Overlapped CNVs
|
n/a
|
11 |
rs182285539 |
chr2:205539351-205539352 |
Enhancers Weak transcription Genic enhancers
|
n/a
|
n/a
|
Overlapped CNVs
|
n/a
|
12 |
rs528721176 |
chr2:205539369-205539370 |
Enhancers Weak transcription Genic enhancers
|
n/a
|
n/a
|
Overlapped CNVs
|
n/a
|
13 |
rs187318573 |
chr2:205539371-205539372 |
Enhancers Weak transcription Genic enhancers
|
n/a
|
n/a
|
Overlapped CNVs
|
n/a
|
14 |
rs571638656 |
chr2:205539415-205539416 |
Enhancers Weak transcription Genic enhancers
|
n/a
|
n/a
|
Overlapped CNVs
|
n/a
|
15 |
rs538968695 |
chr2:205539461-205539462 |
Enhancers Weak transcription Genic enhancers
|
n/a
|
n/a
|
Overlapped CNVs
|
n/a
|
16 |
rs550828669 |
chr2:205539467-205539468 |
Enhancers Weak transcription Genic enhancers
|
n/a
|
n/a
|
Overlapped CNVs
|
n/a
|
17 |
rs568921015 |
chr2:205539520-205539521 |
Enhancers Weak transcription Genic enhancers
|
n/a
|
n/a
|
Overlapped CNVs
|
n/a
|
18 |
rs536602694 |
chr2:205539541-205539542 |
Enhancers Weak transcription Genic enhancers
|
n/a
|
n/a
|
Overlapped CNVs
|
n/a
|
19 |
rs554804517 |
chr2:205539549-205539550 |
Enhancers Weak transcription Genic enhancers
|
n/a
|
n/a
|
Overlapped CNVs
|
n/a
|
20 |
rs77273033 |
chr2:205539568-205539569 |
Enhancers Weak transcription Genic enhancers
|
n/a
|
n/a
|
Overlapped CNVs
|
n/a
|
21 |
rs533774779 |
chr2:205539579-205539580 |
Enhancers Weak transcription Genic enhancers
|
n/a
|
n/a
|
Overlapped CNVs
|
n/a
|
22 |
rs191113926 |
chr2:205539627-205539628 |
Weak transcription Genic enhancers Enhancers
|
n/a
|
n/a
|
Overlapped CNVs
|
n/a
|
23 |
rs577075441 |
chr2:205539631-205539632 |
Weak transcription Genic enhancers Enhancers
|
n/a
|
n/a
|
Overlapped CNVs
|
n/a
|
24 |
rs544524192 |
chr2:205539684-205539685 |
Weak transcription Genic enhancers Enhancers
|
n/a
|
n/a
|
Overlapped CNVs
|
n/a
|
25 |
rs145543955 |
chr2:205539687-205539688 |
Weak transcription Genic enhancers Enhancers
|
n/a
|
n/a
|
Overlapped CNVs
|
n/a
|
26 |
rs183776064 |
chr2:205539734-205539735 |
Weak transcription Genic enhancers Enhancers
|
n/a
|
n/a
|
Overlapped CNVs
|
n/a
|
27 |
rs541802422 |
chr2:205539735-205539736 |
Weak transcription Genic enhancers Enhancers
|
n/a
|
n/a
|
Overlapped CNVs
|
n/a
|
28 |
rs549138518 |
chr2:205539755-205539756 |
Weak transcription Genic enhancers Enhancers
|
n/a
|
n/a
|
Overlapped CNVs
|
n/a
|
29 |
rs188269895 |
chr2:205539801-205539802 |
Weak transcription Enhancers
|
n/a
|
n/a
|
Overlapped CNVs
|
n/a
|
30 |
rs148877143 |
chr2:205539865-205539866 |
Weak transcription Enhancers
|
n/a
|
n/a
|
Overlapped CNVs
|
n/a
|
31 |
rs551829601 |
chr2:205539875-205539876 |
Weak transcription Enhancers
|
n/a
|
n/a
|
Overlapped CNVs
|
n/a
|
32 |
rs113075717 |
chr2:205539884-205539885 |
Weak transcription Enhancers
|
n/a
|
n/a
|
Overlapped CNVs
|
n/a
|
33 |
rs565152911 |
chr2:205539896-205539897 |
Weak transcription Enhancers
|
n/a
|
n/a
|
Overlapped CNVs
|
n/a
|
34 |
rs532529164 |
chr2:205539953-205539954 |
Weak transcription Enhancers
|
n/a
|
n/a
|
Overlapped CNVs
|
n/a
|
35 |
rs550867545 |
chr2:205539994-205539995 |
Weak transcription Enhancers
|
n/a
|
n/a
|
Overlapped CNVs
|
n/a
|
36 |
rs193269963 |
chr2:205540028-205540029 |
Weak transcription
|
n/a
|
n/a
|
Overlapped CNVs
|
n/a
|
37 |
rs142662519 |
chr2:205540047-205540048 |
Weak transcription
|
n/a
|
n/a
|
Overlapped CNVs
|
n/a
|
38 |
rs569205303 |
chr2:205540054-205540055 |
Weak transcription
|
n/a
|
n/a
|
Overlapped CNVs
|
n/a
|
39 |
rs548540839 |
chr2:205540062-205540063 |
Weak transcription
|
n/a
|
n/a
|
Overlapped CNVs
|
n/a
|
40 |
rs183096937 |
chr2:205540079-205540080 |
Weak transcription
|
n/a
|
n/a
|
Overlapped CNVs
|
n/a
|
41 |
rs16836499 |
chr2:205540080-205540081 |
Weak transcription
|
n/a
|
n/a
|
LD-proxies of rSNPOverlapped rCNV
|
n/a
|
42 |
rs35999742 |
chr2:205540121-205540122 |
Weak transcription
|
n/a
|
n/a
|
LD-proxies of rSNPOverlapped rCNV
|
n/a
|
43 |
rs186666706 |
chr2:205540144-205540145 |
Weak transcription
|
n/a
|
n/a
|
Overlapped CNVs
|
n/a
|
44 |
rs538033024 |
chr2:205540158-205540159 |
Weak transcription
|
n/a
|
n/a
|
Overlapped CNVs
|
n/a
|
45 |
rs556540660 |
chr2:205540171-205540172 |
Weak transcription
|
n/a
|
n/a
|
Overlapped CNVs
|
n/a
|
46 |
rs151014023 |
chr2:205540196-205540197 |
Weak transcription
|
n/a
|
n/a
|
Overlapped CNVs
|
n/a
|
47 |
rs191478447 |
chr2:205540216-205540217 |
Weak transcription
|
n/a
|
n/a
|
Overlapped CNVs
|
n/a
|
48 |
rs376129358 |
chr2:205540256-205540257 |
Weak transcription
|
n/a
|
n/a
|
Overlapped CNVs
|
n/a
|
49 |
rs566826896 |
chr2:205540292-205540293 |
Weak transcription
|
n/a
|
n/a
|
Overlapped CNVs
|
n/a
|
50 |
rs571913515 |
chr2:205540358-205540359 |
Weak transcription
|
n/a
|
n/a
|
Overlapped CNVs
|
n/a
|